Medtronic reports strong second quarter fiscal 2026 financial results, enterprise growth drivers accelerate momentum
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Spain's ex-transport minister sentenced to 24 years for corruption
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
Medtronic, Inc. (MDT) PT Raised to $117 at Citi
November 18, 2025 1:46 PM ESTCiti analyst Joanna Wuensch raised the price target on Medtronic, Inc. (NYSE: MDT) to $117.00 (from $112.00) while maintaining a Buy rating.
... MoreMedtronic (MDT) Tops Q2 EPS by 5c, Beats on Revenue; Offers FY26 EPS Guidance
November 18, 2025 6:46 AM ESTMedtronic (NYSE: MDT) reported Q2 EPS of $1.36, $0.05 better than the analyst estimate of $1.31. Revenue for the quarter came in at $9 billion versus the consensus estimate of $8.87 billion.
GUIDANCE:
Medtronic sees FY2026 EPS of $5.62-$5.66, versus the consensus of $5.62.
For earnings history and earnings-related data on Medtronic (MDT) click here.
... More